Research & News
By Michael A. Robinson On July 3, 202508:55 AM Eastern
One company is imprinting its name across America’s $2.3 trillion healthcare system.
By Gavin Magor On July 3, 202507:00 AM Eastern
Take notice when a behemoth like this resecures its ‘buy’ Weiss Rating.
By Chris Graebe On July 2, 202501:20 PM Eastern
Here at midyear, let’s celebrate how far we’ve come … and how much is still ahead.
By Michael A. Robinson On July 2, 202510:15 AM Eastern
And if shares head where I expect them to go, you’re looking at a triple.
By Sean Brodrick On July 2, 202507:00 AM Eastern
It's not gold or silver. So, you haven't missed the buy zone.
Supercycle Investor
Subscription
By Sean Brodrick On July 1, 202512:15 PM Eastern
Your portfolio is banging! Here’s what to watch now.
This Best Momentum ‘Buy’-rated name is feeding profits to the bank.
By Juan M. Villaverde On July 1, 202507:00 AM Eastern
Here are 3 other dates that set up this new catalyst.
By Sean Brodrick On June 30, 202510:00 AM Eastern
Plus, here’s the latest on gold and rare earths.
By Nilus Mattive On June 30, 202507:00 AM Eastern
Here’s why I’m betting against this red-hot crypto IPO.